Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPSAB1 | Q15661 | 2/20 | 0.53 |
| ▸ | TPSD1 | Q9BZJ3 | 2/20 | 0.53 |
| ▸ | TPSG1 | Q9NRR2 | 2/20 | 0.53 |
| ▸ | EPOR | P19235 | 4/20 | 0.47 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CPB1 | P15086 | 1/20 | 0.39 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | SYK | P43405 | 1/20 | 0.39 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | ITGB3 | P05106 | 4/20 | 0.38 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3820596 | 1.00 | TPSAB1 (0.53) | TPSAB1TPSD1TPSG1EPORFOLH1 | |
| SCHEMBL4150947 | 1.00 | TPSAB1 (0.53) | TPSAB1TPSD1TPSG1EPORFOLH1 | |
| SCHEMBL28480221 | 0.97 | TPSAB1 (0.52) | TPSAB1TPSD1TPSG1EPORFOLH1 | |
| SCHEMBL5712142 | 0.97 | TPSAB1 (0.52) | TPSAB1TPSD1TPSG1EPORFOLH1 | |
| SCHEMBL1021829 | 0.97 | TPSAB1 (0.52) | TPSAB1TPSD1TPSG1EPORFOLH1 | |
| SCHEMBL7785339 | 0.93 | TPSAB1 (0.47) | TPSAB1TPSD1TPSG1EPORFOLH1 | |
| SCHEMBL5692891 | 0.91 | EPOR (0.55) | TPSAB1TPSD1TPSG1EPORFOLH1 | |
| SCHEMBL1491987 | 0.91 | EPOR (0.51) | TPSAB1TPSD1TPSG1EPORFOLH1 | |
| SCHEMBL22804052 | 0.91 | EPOR (0.51) | TPSAB1TPSD1TPSG1EPORFOLH1 | |
| SCHEMBL3776750 | 0.91 | EPOR (0.51) | TPSAB1TPSD1TPSG1EPORFOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112110834-A | Modified hydrophobic auxiliary material and preparation method and application thereof | 浙江智达药业有限公司 | 2020-12-22 | — | — | CN | claimed |
| EP-0190058-B1 | PEPTIDE DERIVATIVES WITH A POLYCYCLIC NITROGEN STRUCTURE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ADIR (FR) | 1987-12-23 | — | — | EP | claimed |
| US-20240189486-A1 | ANTIMICROBIAL CATIONIC PEPTOID AND N-SUBTITUTED PEPTIDIC COPOLYMERS, PREPARATION AND USES THEREOF | UNIVERSITÉ DE BORDEAUX (FR) | 2024-06-13 | — | — | US | disclosed |
| EP-4294821-A1 | ANTIMICROBIAL CATIONIC PEPTOID AND N-SUBTITUTED PEPTIDIC COPOLYMERS, PREPARATION AND USES THEREOF | UNIVERSITE DE BORDEAUX (FR) | 2023-12-27 | — | — | EP | disclosed |
| CN-112110834-B | Modified hydrophobic auxiliary material and preparation method and application thereof | 浙江智达药业有限公司 | 2022-10-21 | — | — | CN | disclosed |
| CN-115053184-A | Composition for forming EUV resist underlayer film | 日产化学株式会社 | 2022-09-13 | — | — | CN | disclosed |
| WO-2022175319-A1 | ANTIMICROBIAL CATIONIC PEPTOID AND N-SUBTITUTED PEPTIDIC COPOLYMERS, PREPARATION AND USES THEREOF | Universite de Bordeaux (FR) | 2022-08-25 | — | — | WO | disclosed |
| EP-4047012-A1 | ANTIMICROBIAL CATIONIC PEPTOID AND N-SUBTITUTED PEPTIDIC COPOLYMERS, PREPARATION AND USES THEREOF | Université de Bordeaux (FR) | 2022-08-24 | — | — | EP | disclosed |
| CN-112110834-A | Modified hydrophobic auxiliary material and preparation method and application thereof | 浙江智达药业有限公司 | 2020-12-22 | — | — | CN | disclosed |
| US-9250525-B2 | Resist underlayer film-forming composition | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-02-02 | — | — | US | disclosed |
| US-20150362838-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL IND LTD (JP) | 2015-12-17 | — | — | US | disclosed |
| US-5380872-A | Appetite suppresant, gall bladder disorders, CNS disorders | GLAXO INC. (US) | 1995-01-10 | — | — | US | disclosed |
| WO-1990012811-A1 | LINEAR SOMATOSTATIN ANALOGS | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 1990-11-01 | — | — | WO | disclosed |
| EP-0301087-A4 | HEPTAPEPTIDE. | UNIV TULANE (US) | 1990-06-26 | — | — | EP | disclosed |
| US-4904680-A | IMMUNOLOGY | SANKYO COMPANY, LIMITED (JP) | 1990-02-27 | — | — | US | disclosed |
| EP-0173441-B1 | AMINO ACID DERIVATIVES HAVING ANTI-TUMOR ACTIVITY AND COMPOSITIONS CONTAINING THEM | SANKYO COMPANY LIMITED (JP) | 1990-01-24 | — | — | EP | disclosed |
| US-4871717-A | Peptides | ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 1989-10-03 | — | — | US | disclosed |
| EP-0301087-A1 | HEPTAPEPTIDE. | UNIV TULANE (US) | 1989-02-01 | — | — | EP | disclosed |
| WO-1988005052-A1 | HEPTAPEPTIDE | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 1988-07-14 | — | — | WO | disclosed |
| EP-0173441-A1 | Amino acid derivatives having anti-tumor activity and compositions containing them | SANKYO COMPANY LIMITED (JP) | 1986-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240189486-A1 | ANTIMICROBIAL CATIONIC PEPTOID AND N-SUBTITUTED PEPTIDIC COPOLYMERS, PREPARATION AND USES THEREOF | NGLY1, VIP, FPR3 | TPSAB1 3719/4885TPSD1 2860/4885TPSG1 3648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.